Carbohydrate and lipid metabolism in children after coronavirus disease: Observational study
- Authors: Isaeva E.P.1,2, Zaytseva O.V.2, Lokshina E.Е.2, Zaytseva S.V.1,2, Murtazaeva O.A.1,2, Okorokov P.L.1, Zyabkin I.V.1
-
Affiliations:
- Federal Research and Clinical Center for Children and Adolescents
- Yevdokimov Moscow State University of Medicine and Dentistry
- Issue: No 3 (2022)
- Pages: 244-248
- Section: Articles
- URL: https://pediatria.orscience.ru/2658-6630/article/view/109733
- DOI: https://doi.org/10.26442/26586630.2022.3.201814
- ID: 109733
Cite item
Full Text
Abstract
Background. Six months after coronavirus disease (COVID-19), more than half of the children have various clinical manifestations of post-covid syndrome. In adult patients without a history of diabetes mellitus, cases of carbohydrate metabolism disorders against the background of COVID-19 and in the long term after the disease have been described. Coronavirus infection in adult patients with lipid disorders is associated with a high risk of severe COVID-19. A 12-year follow-up of patients with severe acute respiratory syndrome (SARS) caused by SARS-CoV showed that they were at an increased risk of developing dyslipidemia. For patients who have undergone SARS-CoV-2, there are no such data due to the short follow-up period. Studies in children evaluating the impact of coronavirus disease on the state of carbohydrate and lipid metabolism are isolated and contradictory.
Aim. To compare indicators of carbohydrate and lipid metabolism in children after a coronavirus disease with a control group of healthy peers without a history of COVID-19.
Materials and methods. The study included 108 children aged 3 to 17 years, divided into two groups. The study group included 50 children (mean age 12.0 [7.4; 14.5] years) after a coronavirus disease. The average follow-up period after the disease was 6 months (from 3 to 12 months). The control group consisted of 58 healthy peers (mean age 12.5 [7.5; 15.1] years) without a history of COVID-19. All children underwent an assessment of the level of glucose in the blood serum, lipid metabolism and the calculation of the triglyceride-glucose index (TyG index).
Results. The frequency of impaired fasting glycemia in children after a coronavirus disease was 2% and was comparable to the control group of healthy peers without a history of COVID-19. The TyG indices in the study groups did not differ significantly (4.46 [4.11; 4.65] vs 4.33 [4.0; 4.47]; p=0.37). None of the children included in the study showed an increase in the TyG index to values corresponding to the criterion of insulin resistance. An assessment of the state of lipid metabolism also did not reveal significant differences in the levels of total cholesterol, LDL, HDL and triglycerides, depending on the presence of a history of coronavirus disease.
Conclusion. In children six months (3–12 months) after coronavirus disease, there was no increase in the frequency of impaired fasting glycemia and insulin resistance compared to healthy peers without a history of COVID-19.
Full Text
About the authors
Elena P. Isaeva
Federal Research and Clinical Center for Children and Adolescents; Yevdokimov Moscow State University of Medicine and Dentistry
Author for correspondence.
Email: dora7474@mail.ru
ORCID iD: 0000-0003-0927-0288
Head of the Consulting and Diagnostic center
Russian Federation, Moscow; MoscowOlga V. Zaytseva
Yevdokimov Moscow State University of Medicine and Dentistry
Email: dora7474@mail.ru
ORCID iD: 0000-0003-3426-3426
D. Sci. (Med.), Prof.
Russian Federation, MoscowEvelina Е. Lokshina
Yevdokimov Moscow State University of Medicine and Dentistry
Email: dora7474@mail.ru
ORCID iD: 0000-0001-6006-7846
Cand. Sci. (Med.), Assoc. Prof.
Russian Federation, MoscowSvetlana V. Zaytseva
Federal Research and Clinical Center for Children and Adolescents; Yevdokimov Moscow State University of Medicine and Dentistry
Email: dora7474@mail.ru
ORCID iD: 0000-0003-1685-234X
Cand. Sci. (Med.)
Russian Federation, Moscow; MoscowOlga A. Murtazaeva
Federal Research and Clinical Center for Children and Adolescents; Yevdokimov Moscow State University of Medicine and Dentistry
Email: dora7474@mail.ru
ORCID iD: 0000-0001-6533-099X
Cand. Sci. (Med.)
Russian Federation, Moscow; MoscowPavel L. Okorokov
Federal Research and Clinical Center for Children and Adolescents
Email: pokorokov@gmail.com
ORCID iD: 0000-0001-9834-727X
Cand. Sci. (Med.)
Russian Federation, MoscowIlya V. Zyabkin
Federal Research and Clinical Center for Children and Adolescents
Email: dora7474@mail.ru
ORCID iD: 0000-0002-9717-5872
Cand. Sci. (Med.)
Russian Federation, MoscowReferences
- Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. doi: 10.1542/peds.2020-0702
- Iacobellis G, Penaherrera CA, Bermudez LE, et al. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes. Diabetes Res Clin Pract. 2020;164:108185. doi: 10.1016/j.diabres.2020.108185
- Wu Q, Zhou L, Sun X, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7(1):9110. doi: 10.1038/s41598-017-09536-z
- Calcaterra V, Bosoni P, Dilillo D, et al. Impaired Glucose-Insulin Metabolism in Multisystem Inflammatory Syndrome Related to SARS-CoV-2 in Children. Children (Basel). 2021;8(5):384. doi: 10.3390/children8050384
- Nielsen-Saines K, Li E, Olivera AM, et al. Case Report: Insulin-Dependent Diabetes Mellitus and Diabetic Keto-Acidosis in a Child With COVID-19. Front Pediatr. 2021;9(16):62810. doi: 10.3389/fped.2021.628810
- Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347-51. doi: 10.1210/jc.2010-0288
- Vieira-Ribeiro SA, Fonseca PCA, Andreoli CS, et al. The TyG Index Cutoff Point and Its Association with Body Adiposity and Lifestyle in Children. J Pediatr. 2019;95:217-23. doi: 10.1016/j.jped.2017.12.012
- Иванова О.Н. Постковидный синдром у детей. Международный научно-исследовательский журнал. 2021;111(9):35-9 [Ivanova ON. Post-COVID syndrome in children. International Research Journal. 2021;111(9):35-9 (in Russian)]. doi: 10.23670/IRJ.2021.9.111.040
- Захарова И.Н., Османов И.М., Творогова Т.М., и др. Постковидный синдром у детей в структуре COVID-19. Педиатрия. Consilium Medicum. 2022;1:8-14 [Zakharova IN, Osmanov IM, Tvorogova TM, et al. Post-covid syndrome in children in rare cases of COVID-19. Pediatrics. Consilium Medicum. 2022;1:8-14 (in Russian)]. doi: 10.26442/26586630.2022.1.201515
- Калмыкова З.А., Кононенко И.В., Скляник И.А., и др. Гипергликемия и возможные механизмы повреждения β-клеток у пациентов с COVID-19. Сахарный диабет. 2020;23(3):229-34 [Kalmykova ZA, Kononenko IV, Sklyanik IA, et al. Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19. Diabetes Mellitus. 2020;23(3):229-34 (in Russian)]. doi: 10.14341/DM12485
- Salazar J, Bermúdez V, Calvo M, et al. Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population. F1000Res. 2017;6:1337. doi: 10.12688/f1000research.12170.3
- Lee SH, Kwon HS, Park YM, et al. Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study. PLoS One. 2014;9(2):e90430. doi: 10.1371/journal.pone.0090430